Home » FDA to Launch New Board to Improve Monitoring of Supply Chain
FDA to Launch New Board to Improve Monitoring of Supply Chain
The FDA’s Center for Drug Evaluation and Research (CDER) is setting up a new board to strengthen pharmaceutical supply-chain monitoring in the wake of COVID-19-related drug shortages.
The Pharmaceutical Supply Chain Governance Board, which will get under way next month, is tasked with coordinating all CDER supply-chain initiatives and providing guidance and fixes for major supply-chain issues.
This will include overseeing the ongoing development for the agency’s existing Drug Supply-Chain System used to monitor shortages, which was first implemented last fall.
Jacqueline Corrigan-Curay, CDER’s principal deputy center director, will chair the new board.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May